Blossomhill Therapeutics, Inc. · NASDAQ:BLSM
Perceptive Advisors LLC reported a 5.90% stake in Blossomhill Therapeutics, Inc. (Schedule 13G)
Event Aug 7, 2026 · Filed Aug 14, 2026
Perceptive Advisors LLC reported a 5.90% stake in Blossomhill Therapeutics, Inc., 1,808,533 shares, as a passive investor on Aug 7, 2026. Filed Aug 14, 2026 (Schedule 13G).
- Stake
- 5.90%
- Shares
- 1,808,533
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Perceptive Advisors LLC | 5.90% | 1,808,533 |
| Joseph Edelman | 5.90% | 1,808,533 |
| Perceptive Life Sciences Master Fund, Ltd. | 5.90% | 1,808,533 |
Source
Related
- Blossomhill Therapeutics, Inc.
- Perceptive Advisors LLC
- Blossomhill Therapeutics, Inc. shareholders
- Schedule 13D · Orbimed Advisors LLC · Aug 18, 2026
- Schedule 13G · Vivo Innovation Fund II Holdings, L.P. · Aug 17, 2026
- Schedule 13D · Chen Bihua · Aug 13, 2026
- Form 4 · Gordon Carl L · Aug 12, 2026
- Form 4 · OrbiMed Capital GP VIII LLC · Aug 12, 2026